{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:28:51Z","timestamp":1792427331760,"version":"4.5.0"},"reference-count":116,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/pm\/pnz075","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T17:14:56Z","timestamp":1553015696000},"page":"S2-S12","source":"Crossref","is-referenced-by-count":349,"title":["A Comprehensive Algorithm for Management of Neuropathic Pain"],"prefix":"10.1093","volume":"20","author":[{"given":"Daniel","family":"Bates","sequence":"first","affiliation":[{"name":"Metro Pain Group, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B Carsten","family":"Schultheis","sequence":"additional","affiliation":[{"name":"Muskuloskelettales Zentrum - Interventionelle Schmerztherapie, Krankenhaus Neuwerk \u201cMaria von den Aposteln,\u201d M\u00f6nchengladbach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Hanes","sequence":"additional","affiliation":[{"name":"Jax Spine & Pain Centers, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneil M","family":"Jolly","sequence":"additional","affiliation":[{"name":"Louisiana Pain Specialists, New Orleans, Louisiana"},{"name":"New Orleans East Hospital, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan V","family":"Chakravarthy","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of California San Diego Health Sciences, La Jolla, California"},{"name":"Veterans Administration San Diego Healthcare System, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Deer","sequence":"additional","affiliation":[{"name":"The Spine and Nerve Center of the Virginias, Charleston, West Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Levy","sequence":"additional","affiliation":[{"name":"Institute for Neuromodulation, Boca Raton, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey W","family":"Hunter","sequence":"additional","affiliation":[{"name":"Ainsworth Institute of Pain Management, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"key":"2019060808093711800_pnz075-B1","year":"2013"},{"issue":"2","key":"2019060808093711800_pnz075-B2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis and updated NeuPSIG recommendations","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"issue":"3","key":"2019060808093711800_pnz075-B3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00540-018-2501-0","article-title":"Executive summary of the clinical guidelines of pharmacologic therapy for neuropathic pain: Second edition by the Japanese Society or Pain Clinicians","volume":"32","author":"Sumitani","year":"2018","journal-title":"J Anesth"},{"issue":"3","key":"2019060808093711800_pnz075-B4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"3","key":"2019060808093711800_pnz075-B5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pain.2008.03.002","article-title":"Incidence rates and treatment of neuropathic pain conditions in the general population","volume":"137","author":"Dieleman","year":"2008","journal-title":"Pain"},{"issue":"1","key":"2019060808093711800_pnz075-B6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment","volume":"152","author":"Haanp\u00e4\u00e4","year":"2011","journal-title":"Pain"},{"issue":"8","key":"2019060808093711800_pnz075-B7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1468-1331.2010.02969.x","article-title":"EFNS guidelines on neuropathic pain assessment: Revised 2009","volume":"17","author":"Cruccu","year":"2010","journal-title":"Eur J Neurol"},{"key":"2019060808093711800_pnz075-B8","first-page":"e67","article-title":"European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"2019060808093711800_pnz075-B9","first-page":"844","article-title":"Pharmacological management of chronic neuropathic pain. Review of the Canadian Pain Society consensus statement","volume":"63","author":"Mu","year":"2017","journal-title":"Can Fam Physician"},{"issue":"8","key":"2019060808093711800_pnz075-B10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol"},{"issue":"9","key":"2019060808093711800_pnz075-B11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1468-1331.2007.01916.x","article-title":"EFNS guidelines on neurostimulation therapy for neuropathic pain","volume":"14","author":"Cruccu","year":"2007","journal-title":"Eur J Neurol"},{"issue":"4","key":"2019060808093711800_pnz075-B12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1525-1403.2011.00373.x","article-title":"Using the SAFE principles when evaluating electrical stimulation therapies for the pain of failed back surgery syndrome","volume":"14","author":"Krames","year":"2011","journal-title":"Neuromodulation"},{"key":"2019060808093711800_pnz075-B13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: An overview and literature update","volume":"85(3, Suppl)","author":"Dworkin","year":"2010","journal-title":"Mayo Clinic Proc"},{"key":"2019060808093711800_pnz075-B14","author":"NHMRC","year":"2018"},{"issue":"2","key":"2019060808093711800_pnz075-B15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The Polyanalgesic Consensus Conference (PACC): Recommendations on intrathecal drug infusion systems: Best practices and guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"issue":"11","key":"2019060808093711800_pnz075-B16","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.pain.2013.06.004","article-title":"Interventional management of neuropathic pain: NeuPSIG recommendations","volume":"154","author":"Dworkin","year":"2013","journal-title":"Pain"},{"issue":"10","key":"2019060808093711800_pnz075-B17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/BRS.0b013e3181a1390d","article-title":"Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: An evidence-based clinical practice guideline from the American Pain Society","volume":"34","author":"Chou","year":"2009","journal-title":"Spine (Phila Pa 1976)"},{"key":"2019060808093711800_pnz075-B18","first-page":"S49","article-title":"An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: Guidance and recommendations","volume":"16","author":"Manchikanti","year":"2013","journal-title":"Pain Physician"},{"issue":"SA","key":"2019060808093711800_pnz075-B19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/eujp.2001.0322","article-title":"Neuropathic pain: Clinical characteristics and diagnostic workup","volume":"6","author":"Hansson","year":"2002","journal-title":"Eur J Pain"},{"issue":"2","key":"2019060808093711800_pnz075-B20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","article-title":"Peripheral neuropathic pain: A mechanism-related organising principle based on sensory profiles","volume":"158","author":"Baron","year":"2017","journal-title":"Pain"},{"issue":"10","key":"2019060808093711800_pnz075-B21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"PainDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"1\u20132","key":"2019060808093711800_pnz075-B22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"issue":"1\u20132","key":"2019060808093711800_pnz075-B23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3959(00)00482-6","article-title":"The LANSS pain scale: The Leeds Assessment of Neuropathic Symptoms and Signs","volume":"92","author":"Bennett","year":"2001","journal-title":"Pain"},{"issue":"2","key":"2019060808093711800_pnz075-B24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"issue":"1","key":"2019060808093711800_pnz075-B25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3959(86)90228-9","article-title":"The measurement of clinical pain intensity: A comparison of six methods","volume":"27","author":"Jensen","year":"1986","journal-title":"Pain"},{"issue":"1","key":"2019060808093711800_pnz075-B26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3111\/13696998.2012.729548","article-title":"The burden associated with neuropathic pain in Western Europe","volume":"16","author":"Langley","year":"2013","journal-title":"J Med Econ"},{"key":"2019060808093711800_pnz075-B27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40122-017-0087-0","article-title":"A review of neuropathic pain: From guidelines to clinical practice","volume":"6(Suppl 1)","author":"Cruccu","year":"2017","journal-title":"Pain Ther"},{"issue":"2","key":"2019060808093711800_pnz075-B28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3959(90)90068-O","article-title":"The Pain Disability Index: Psychometric properties","volume":"40","author":"Tait","year":"1990","journal-title":"Pain"},{"key":"2019060808093711800_pnz075-B29","volume-title":"BDI-II: Beck Depression Inventory Manual","author":"Beck","year":"1996","edition":"2nd ed"},{"key":"2019060808093711800_pnz075-B30"},{"issue":"2","key":"2019060808093711800_pnz075-B31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"issue":"1","key":"2019060808093711800_pnz075-B32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1037\/1040-3590.7.1.80","article-title":"Short Form of the Profile of Mood States (POMS-SF): Psychometric information","volume":"7","author":"Curran","year":"1995","journal-title":"Psychol Assess"},{"issue":"4","key":"2019060808093711800_pnz075-B33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The Pain Catastrophizing Scale: Development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol Assess"},{"issue":"2","key":"2019060808093711800_pnz075-B34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3959(94)00118-X","article-title":"The Chronic Pain Coping Inventory: Development and preliminary validation","volume":"60","author":"Jensen","year":"1995","journal-title":"Pain"},{"issue":"5","key":"2019060808093711800_pnz075-B35","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.pain.2011.01.028","article-title":"Norming of the Tampa Scale for Kinesiophobia across pain diagnoses and various countries","volume":"152","author":"Roelofs","year":"2011","journal-title":"Pain"},{"issue":"2","key":"2019060808093711800_pnz075-B36","first-page":"129","article-title":"Pain assessment: Global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"2019060808093711800_pnz075-B37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","author":"The EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"2019060808093711800_pnz075-B38","volume-title":"Quality Metric, Inc. User\u2019s Manual for the SF-36(v2) Health Survey","year":"2007","edition":"2nd ed"},{"issue":"3","key":"2019060808093711800_pnz075-B39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pain.2005.01.015","article-title":"Sensory function and quality of life in patients with multiple sclerosis and pain","volume":"114","author":"Svendsen","year":"2005","journal-title":"Pain"},{"key":"2019060808093711800_pnz075-B40","doi-asserted-by":"crossref","first-page":"1\u20135.","DOI":"10.1371\/journal.pmed.1000045","article-title":"Tools for assessing neuropathic pain","volume":"6","author":"Cruccu","year":"2009","journal-title":"PLoS Med"},{"issue":"8","key":"2019060808093711800_pnz075-B41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1526-4637.2010.00914.x","article-title":"Vasomotor disturbances in complex regional pain syndrome - a review","volume":"11","author":"Wasner","year":"2010","journal-title":"Pain Med"},{"key":"2019060808093711800_pnz075-B42","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.amjmed.2009.04.006","article-title":"Assessment of neuropathic pain in primary care","volume":"122(Suppl 10)","author":"Haanp\u00e4\u00e4","year":"2009","journal-title":"Am J Med"},{"issue":"4","key":"2019060808093711800_pnz075-B43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00003081-200312000-00009","article-title":"Chronic pelvic pain as a form of complex regional pain syndrome","volume":"46","author":"Janicki","year":"2003","journal-title":"J Clin Gynecol Obstet"},{"key":"2019060808093711800_pnz075-B44","author":"NICE pain overview","year":"2018"},{"key":"2019060808093711800_pnz075-B45","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/JPR.S175817","article-title":"Predicting factors of outcome in multidisciplinary treatment of chronic neuropathic pain","volume":"11","author":"Shaygan","year":"2018","journal-title":"J Pain Res"},{"key":"2019060808093711800_pnz075-B46","first-page":"CD005454","article-title":"Antidepressants for neuropathic pain","volume":"4","author":"Saarto","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2019060808093711800_pnz075-B47","doi-asserted-by":"crossref","first-page":"2483.","DOI":"10.3390\/ijms18112483","article-title":"Analgesic mechanisms of antidepressants for pain","volume":"18","author":"Obata","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2019060808093711800_pnz075-B48","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/WCO.0b013e3283311e13","article-title":"Pharmacology and treatment of neuropathic pains","volume":"22","author":"Jensen","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"2019060808093711800_pnz075-B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the treatment of neuropathic pain","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2019060808093711800_pnz075-B50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7224\/1537-2073.2014-001","article-title":"A randomized placebo-controlled trial of duloxetine for central pain in multiple sclerosis","volume":"17","author":"Brown","year":"2015","journal-title":"Int J MS Care"},{"issue":"6","key":"2019060808093711800_pnz075-B51","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","article-title":"Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats","volume":"21","author":"Luo","year":"2001","journal-title":"J Neurosci"},{"issue":"1","key":"2019060808093711800_pnz075-B52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain \u2013 consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manage"},{"issue":"3","key":"2019060808093711800_pnz075-B53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/AJP.0b013e3181934276","article-title":"Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: Results of a double-blind, randomized, placebo-controlled clinical trial","volume":"25","author":"Irving","year":"2009","journal-title":"Clin J Pain"},{"issue":"4","key":"2019060808093711800_pnz075-B54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/AJP.0b013e318192bf87","article-title":"Assessment of pain quality in a clinical trial of gabapentin extended release for\u00a0postherpetic neuralgia","volume":"25","author":"Jensen","year":"2009","journal-title":"Clin J Pain"},{"issue":"2","key":"2019060808093711800_pnz075-B55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1185\/030079906X80404","article-title":"Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial","volume":"22","author":"van Seventer","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"2019060808093711800_pnz075-B56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"2019060808093711800_pnz075-B57","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-8-33","article-title":"Efficacy and safety of pregabalin 600 mg\/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial","volume":"8","author":"Arezzo","year":"2008","journal-title":"BMC Neurol"},{"issue":"10","key":"2019060808093711800_pnz075-B58","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/01.wnl.0000244422.45278.ff","article-title":"Pregabalin in central neuropathic pain associated with spinal cord injury: A placebo-controlled trial","volume":"67","author":"Siddall","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"2019060808093711800_pnz075-B59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2007.06.033","article-title":"Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen","volume":"136","author":"Vranken","year":"2008","journal-title":"Pain"},{"key":"2019060808093711800_pnz075-B60","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2019060808093711800_pnz075-B61","author":"Sicras-Mainar"},{"key":"2019060808093711800_pnz075-B62","first-page":"505","article-title":"Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan","volume":"7","author":"Igarashi","year":"2015","journal-title":"Clinicoecon Outcomes Res"},{"issue":"8","key":"2019060808093711800_pnz075-B63","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.clinthera.2007.08.019","article-title":"A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings","volume":"29","author":"Gore","year":"2007","journal-title":"Clin Ther"},{"issue":"11","key":"2019060808093711800_pnz075-B64","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"issue":"4","key":"2019060808093711800_pnz075-B65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00520-008-0542-x","article-title":"Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: A phase III double-blind crossover study (N01CB)","volume":"17","author":"Cheville","year":"2009","journal-title":"Support Care Cancer"},{"issue":"1","key":"2019060808093711800_pnz075-B66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/AJP.0b013e318156db26","article-title":"Topical amitriptyline versus lidocaine in the treatment of neuropathic pain","volume":"24","author":"Ho","year":"2008","journal-title":"Clin J Pain"},{"key":"2019060808093711800_pnz075-B67","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1185\/03007990903047880","article-title":"5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: An open-label, non-inferiority two-stage RCT study","volume":"27","author":"Baron","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"2019060808093711800_pnz075-B68","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00002508-200209000-00004","article-title":"The lidocaine patch 5% effectively treats all neuropathic pain qualities: Results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale","volume":"18","author":"Galer","year":"2002","journal-title":"Clin J Pain"},{"issue":"3","key":"2019060808093711800_pnz075-B69","doi-asserted-by":"crossref","first-page":"15.","DOI":"10.1007\/s11916-017-0615-y","article-title":"Topical treatments for localized neuropathic pain","volume":"21","author":"Casale","year":"2017","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"2019060808093711800_pnz075-B70","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bja\/aer260","article-title":"Topical capsaicin for pain management: Therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch","volume":"107","author":"Anand","year":"2011","journal-title":"Br J Anaesth"},{"key":"2019060808093711800_pnz075-B71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/JPR.S9492","article-title":"Topical preparations for pain relief: Efficacy and patient adherence","volume":"4","author":"Jorge","year":"2010","journal-title":"J Pain Res"},{"key":"2019060808093711800_pnz075-B72","first-page":"CD007393","article-title":"Topical capsaisan (high concentrations) for chronic neuropathic pain in adults","volume":"1","author":"Derry","year":"2017","journal-title":"Cochrane Database of Syst Rev"},{"issue":"1\u20132","key":"2019060808093711800_pnz075-B73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pain.2009.05.017","article-title":"Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine","volume":"146","author":"Finch","year":"2009","journal-title":"Pain"},{"issue":"3","key":"2019060808093711800_pnz075-B74","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1590\/S0365-05962012000300032","article-title":"Topical (S)-ketamine for pain management of postherpetic neuralgia","volume":"87","author":"Barros","year":"2012","journal-title":"An Bras Dermatol"},{"issue":"3","key":"2019060808093711800_pnz075-B75","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7547\/1020178","article-title":"Topical ketamine cream in the treatment of painful diabetic neuropathy: A randomized, placebo-controlled, double-blind initial study","volume":"102","author":"Mahoney","year":"2012","journal-title":"J Am Podiatr Med Assoc"},{"issue":"1","key":"2019060808093711800_pnz075-B76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/ALN.0000000000000693","article-title":"Effect of 1.5% topical diclofenac on clinical neuropathic pain","volume":"123","author":"Ahmed","year":"2015","journal-title":"Anesthesiology"},{"issue":"9","key":"2019060808093711800_pnz075-B77","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.pain.2012.04.014","article-title":"Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy","volume":"153","author":"Campbell","year":"2012","journal-title":"Pain"},{"key":"2019060808093711800_pnz075-B78","first-page":"CD10967","article-title":"Topical clonidine for neuropathic pain","volume":"8","author":"Wrzosek","year":"2015","journal-title":". Cochrane Database Syst Rev"},{"issue":"1\u20134","key":"2019060808093711800_pnz075-B79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3111\/200609055068","article-title":"The economic burden of neuropathic pain in Canada","volume":"9","author":"Tarride","year":"2006","journal-title":"J Med Econ"},{"issue":"6","key":"2019060808093711800_pnz075-B80","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejpain.2007.12.010","article-title":"Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients","volume":"12","author":"Hanna","year":"2008","journal-title":"Eur J Pain"},{"key":"2019060808093711800_pnz075-B81","first-page":"CD08943","article-title":"Gilron Combination pharmacotherapy for the treatment of neuropathic pain in adults","volume":"7","author":"Chapparo","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"2019060808093711800_pnz075-B82","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.pain.2013.05.043","article-title":"Duloxetine and pregabalin: High-dose monotherapy or their combination? The \u201cCOMBO-DN study\u201d- a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain","volume":"154","author":"Tesfaye","year":"2013","journal-title":"Pain"},{"issue":"9697","key":"2019060808093711800_pnz075-B83","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"2019060808093711800_pnz075-B84","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/j.pain.0000000000000143","article-title":"Imipramine and pregabalin combination for painful polyneuropathy: A randomized controlled trial","volume":"156","author":"Holbech","year":"2015","journal-title":"Pain"},{"issue":"1","key":"2019060808093711800_pnz075-B85","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","article-title":"Tramadol relieves pain and allodynia in polyneuropathy: A randomized, double-blind, controlled trial","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"issue":"1\u20132","key":"2019060808093711800_pnz075-B86","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","article-title":"Tramadol in post-herpetic neuralgia: A randomized, double-blind, placebo-controlled trial","volume":"104","author":"Boureau","year":"2003","journal-title":"Pain"},{"issue":"1","key":"2019060808093711800_pnz075-B87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00044011-200727010-00007","article-title":"Tramadol in the treatment of neuropathic cancer pain: A double-blind, placebo-controlled study","volume":"27","author":"Arbaiza","year":"2007","journal-title":"Clin Drug Invest"},{"issue":"1","key":"2019060808093711800_pnz075-B88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1185\/03007995.2010.537589","article-title":"Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: Results of a randomized-withdrawal, placebo-controlled trial","volume":"27","author":"Schwartz","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"2019060808093711800_pnz075-B89","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pmrj.2016.11.008","article-title":"Systematic review of the efficacy of particulate versus nonparticulate corticosteroids in epidural injections","volume":"9","author":"Mehta","year":"2017","journal-title":"PM R"},{"issue":"4","key":"2019060808093711800_pnz075-B90","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00701-010-0881-5","article-title":"Pulsed radiofrequency treatment in interventional pain management: Mechanisms and potential indications\u2014a review","volume":"153","author":"Chua","year":"2011","journal-title":"Acta Neurochir (Wien)"},{"key":"2019060808093711800_pnz075-B91","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.36076\/ppj.2018.3.E225","article-title":"Efficacy of pulsed radiofrequency stimulation in patients with peripheral neuropathic pain: A narrative review","volume":"21","author":"Chang","year":"2018","journal-title":"Pain Physician"},{"issue":"7","key":"2019060808093711800_pnz075-B92","first-page":"429","article-title":"Treatment of neuropathic pain using pulsed radiofrequency: A meta-analysis","volume":"19","author":"Shi","year":"2016","journal-title":"Pain Physician"},{"issue":"31","key":"2019060808093711800_pnz075-B93","doi-asserted-by":"crossref","first-page":"e11761.","DOI":"10.1097\/MD.0000000000011761","article-title":"Effectiveness of pulsed radiofrequency treatment on cervical radicular pain: A meta-analysis","volume":"97","author":"Kwak","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2019060808093711800_pnz075-B94","first-page":"CD004598","article-title":"Local anaesthetic sympathetic blockade for complex regional pain syndrome","volume":"7","author":"O'Connell","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2019060808093711800_pnz075-B95","first-page":"1127","article-title":"Radiofrequency lesion adjacent to the dorsal root ganglion for cervicobrachial pain: A prospective double-blind randomized study","volume":"38","author":"Kleef","year":"1996","journal-title":"Neurosurgery"},{"key":"2019060808093711800_pnz075-B96","author":"NICE pain overview","year":"2018"},{"key":"2019060808093711800_pnz075-B97","year":"2014"},{"key":"2019060808093711800_pnz075-B98","author":"Lamer"},{"issue":"9","key":"2019060808093711800_pnz075-B99","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain. The SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"key":"2019060808093711800_pnz075-B100","author":"Centers for Disease Control and Prevention","year":"2018"},{"issue":"6","key":"2019060808093711800_pnz075-B101","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Controlled release oxycodone for pain in diabetic neuropathy: A randomized controlled trial","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"},{"issue":"1\u20132","key":"2019060808093711800_pnz075-B102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3959(00)00385-7","article-title":"The effect of opioids on phantom limb pain and cortical reorganization","volume":"90","author":"Huse","year":"2001","journal-title":"Pain"},{"issue":"24","key":"2019060808093711800_pnz075-B103","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.293.24.3043","article-title":"Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignent origin: Systemic review and meta-analysis of randomized controlled trials","volume":"293","author":"Eisenberg","year":"2005","journal-title":"JAMA"},{"issue":"7","key":"2019060808093711800_pnz075-B104","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"issue":"13","key":"2019060808093711800_pnz075-B105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain","volume":"348","author":"Rowbotham","year":"2003","journal-title":"N Eng J Med"},{"key":"2019060808093711800_pnz075-B106","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","article-title":"Efficacy of oxycodon in neuropathic pain: A randomized trial in postherpetic neuralgia","volume":"50","author":"Watson","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"2019060808093711800_pnz075-B107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","article-title":"Controlled-release oxycodon relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy","volume":"105","author":"Watson","year":"2003","journal-title":"Pain"},{"key":"2019060808093711800_pnz075-B108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"key":"2019060808093711800_pnz075-B109","first-page":"CD011669","article-title":"Morphine for chronic neuropathic pain in adults","volume":"5","author":"Cooper","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2019060808093711800_pnz075-B110","first-page":"CD010692","article-title":"Oxycodone for neuropathic pain in adults","volume":"7","author":"Gaskell","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2019060808093711800_pnz075-B111","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"issue":"3","key":"2019060808093711800_pnz075-B112","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: An evidence-based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"2019060808093711800_pnz075-B113","author":"Centers for Disease Control and Prevention","year":"2018"},{"issue":"18","key":"2019060808093711800_pnz075-B114","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and non-cancer pain","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"issue":"1","key":"2019060808093711800_pnz075-B115","doi-asserted-by":"crossref","first-page":"388.","DOI":"10.1007\/s11916-013-0388-x","article-title":"Intrathecal therapy for chronic pain: Current trends and future needs","volume":"18","author":"Hayek","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"8","key":"2019060808093711800_pnz075-B116","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/ner.12263","article-title":"A definition of refractory pain to help determine suitability for device implantation","volume":"17","author":"Deer","year":"2014","journal-title":"Neuromodulation"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/20\/Supplement_1\/S2\/28786730\/pnz075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T17:11:46Z","timestamp":1574356306000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/20\/Supplement_1\/S2\/5509427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":116,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2019,6,1]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnz075","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,6,1]]}}}